[go: up one dir, main page]

GB0804317D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0804317D0
GB0804317D0 GB0804317A GB0804317A GB0804317D0 GB 0804317 D0 GB0804317 D0 GB 0804317D0 GB 0804317 A GB0804317 A GB 0804317A GB 0804317 A GB0804317 A GB 0804317A GB 0804317 D0 GB0804317 D0 GB 0804317D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB0804317A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0804317A priority Critical patent/GB0804317D0/en
Publication of GB0804317D0 publication Critical patent/GB0804317D0/en
Priority to US12/664,945 priority patent/US20120095034A1/en
Priority to KR1020097027582A priority patent/KR20100030635A/en
Priority to CN200880105361A priority patent/CN101796053A/en
Priority to EA201070091A priority patent/EA201070091A1/en
Priority to EP08785891A priority patent/EP2176258A1/en
Priority to ARP080102851A priority patent/AR067396A1/en
Priority to CL2008001951A priority patent/CL2008001951A1/en
Priority to PE2008001119A priority patent/PE20090441A1/en
Priority to AU2008270294A priority patent/AU2008270294A1/en
Priority to PCT/EP2008/058423 priority patent/WO2009003993A1/en
Priority to TW097124654A priority patent/TW200911242A/en
Priority to US12/165,894 priority patent/US20090022670A1/en
Priority to BRPI0812981-9A2A priority patent/BRPI0812981A2/en
Priority to CA002691638A priority patent/CA2691638A1/en
Priority to JP2010513961A priority patent/JP2010531848A/en
Priority to IL202665A priority patent/IL202665A0/en
Priority to DO2009000293A priority patent/DOP2009000293A/en
Priority to CO09149373A priority patent/CO6270320A2/en
Priority to MA32459A priority patent/MA31470B1/en
Pending legal-status Critical Current

Links

GB0804317A 2007-07-03 2008-03-07 Novel compounds Pending GB0804317D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
GB0804317A GB0804317D0 (en) 2008-03-07 2008-03-07 Novel compounds
JP2010513961A JP2010531848A (en) 2007-07-03 2008-07-01 Piperidine derivatives useful as orexin receptor antagonists
PE2008001119A PE20090441A1 (en) 2007-07-03 2008-07-01 DERIVATIVES OF IMIDAZO [1,2-a] PYRIDIN-2-ILMETIL PIPERIDINE SUBSTITUTE
PCT/EP2008/058423 WO2009003993A1 (en) 2007-07-03 2008-07-01 Piperidine derivatives useful as orexin receptor antagonists
CN200880105361A CN101796053A (en) 2007-07-03 2008-07-01 Piperidine derivatives useful as orexin receptor antagonists
EA201070091A EA201070091A1 (en) 2007-07-03 2008-07-01 DERIVATIVES OF PIPERIDINE, SUITABLE AS ANTAGONISTS OF OREXIN RECEPTOR
EP08785891A EP2176258A1 (en) 2007-07-03 2008-07-01 Piperidine derivatives useful as orexin receptor antagonists
ARP080102851A AR067396A1 (en) 2007-07-03 2008-07-01 COMPOUND DERIVED FROM IMIDAZO (1,2-A) PIRIDIN-2-ILMETIL PIPERIDINA REPLACED HYDROCHLORIDE SALT OF THE SAME USE OF THE COMPOUND OR OF THE HYDROCHLORIDE SALT FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
CL2008001951A CL2008001951A1 (en) 2007-07-03 2008-07-01 Substituted imidazo [1,2-a] pyrimidin-2-ylmethyl derived compounds; pharmaceutical composition comprising said compound; and use of the compound for sleep disorder, depression, anxiety, substance abuse-related disorder, among others.
US12/664,945 US20120095034A1 (en) 2007-07-03 2008-07-01 Piperidine derivatives useful as orexin receptor antagonists
AU2008270294A AU2008270294A1 (en) 2007-07-03 2008-07-01 Piperidine derivatives useful as orexin receptor antagonists
KR1020097027582A KR20100030635A (en) 2007-07-03 2008-07-01 Piperidine derivatives useful as orexin receptor antagonists
TW097124654A TW200911242A (en) 2007-07-03 2008-07-01 Novel compounds
US12/165,894 US20090022670A1 (en) 2007-07-03 2008-07-01 Novel compounds
BRPI0812981-9A2A BRPI0812981A2 (en) 2007-07-03 2008-07-01 PIPERIDINE DERIVATIVES USEFUL AS OREXIN RECEPTOR ANTAGONISTS
CA002691638A CA2691638A1 (en) 2007-07-03 2008-07-01 Piperidine derivatives useful as orexin receptor antagonists
IL202665A IL202665A0 (en) 2007-07-03 2009-12-10 Piperidine derivatives useful as orexin receptor antagonists
DO2009000293A DOP2009000293A (en) 2007-07-03 2009-12-29 USED PIPERIDINE DERIVATIVES AS OREXIN RECEIVING ANTAGONISTS.
CO09149373A CO6270320A2 (en) 2007-07-03 2009-12-30 USEFUL PIPERIDINE DERIVATIVES AS AN OREXINE RECEIVER ANTAGONISTS
MA32459A MA31470B1 (en) 2007-07-03 2009-12-30 Oxidative derivatives are useful as antioxidants for orexin receptors.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0804317A GB0804317D0 (en) 2008-03-07 2008-03-07 Novel compounds

Publications (1)

Publication Number Publication Date
GB0804317D0 true GB0804317D0 (en) 2008-04-16

Family

ID=39327751

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0804317A Pending GB0804317D0 (en) 2007-07-03 2008-03-07 Novel compounds

Country Status (1)

Country Link
GB (1) GB0804317D0 (en)

Similar Documents

Publication Publication Date Title
GB0823467D0 (en) Novel Compounds
GB0806536D0 (en) Novel compounds
GB0800035D0 (en) Compounds
GB0813142D0 (en) Novel compounds
GB0811587D0 (en) Novel Compounds
GB0808747D0 (en) Novel compounds
IL212799A0 (en) Novel compounds
GB0812849D0 (en) Novel compounds
GB0804592D0 (en) Novel compounds
GB0810981D0 (en) Novel compounds
GB0810228D0 (en) Novel compounds
IL213032A0 (en) Novel compounds
GB0813144D0 (en) Novel compounds
GB0808030D0 (en) Novel compounds
GB0804326D0 (en) Novel compounds
GB0800411D0 (en) Novel compounds
GB0809479D0 (en) Novel compounds
GB0804585D0 (en) Novel compounds
GB0804317D0 (en) Novel compounds
GB0806289D0 (en) Novel compounds
GB0807050D0 (en) Novel compounds
GB0807497D0 (en) Novel compounds
GB0807498D0 (en) Novel compounds
GB0805275D0 (en) Novel compounds
GB0805273D0 (en) Novel compounds